Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from MiNK Therapeutics ( (INKT) ) is now available.
On December 29, 2025, Robert Kadlec, MD, resigned from the Board of Directors of MiNK Therapeutics, Inc., including all committee roles, following his acceptance of a senior public service appointment as Assistant Secretary of War for Nuclear Deterrence and Chemical and Biological Defense Policy and Programs in the U.S. government. Dr. Kadlec, who joined the board in October 2024, had provided the company with strategic insights drawn from his extensive background in medicine, public health preparedness, and national service, and his departure reflects both the prestige of his new role and MiNK’s connections to high-level expertise, with the company publicly thanking him for his contributions and service during his tenure.
The most recent analyst rating on (INKT) stock is a Hold with a $12.00 price target. To see the full list of analyst forecasts on MiNK Therapeutics stock, see the INKT Stock Forecast page.
Spark’s Take on INKT Stock
According to Spark, TipRanks’ AI Analyst, INKT is a Neutral.
The score is primarily held down by weak financial fundamentals (pre-revenue, negative equity, and highly concerning TTM cash flow metrics). This is partially offset by a constructive earnings call centered on clinical progress and runway, while technicals and valuation provide limited additional support.
To see Spark’s full report on INKT stock, click here.
More about MiNK Therapeutics
MiNK Therapeutics, Inc. operates in the biotechnology and life sciences sector, focusing on developing innovative cell-based therapies. The company leverages expertise in medicine and public health preparedness through its leadership and advisors to advance its therapeutic pipeline and position itself within the immunotherapy and advanced therapeutics market.
Average Trading Volume: 22,816
Technical Sentiment Signal: Hold
Current Market Cap: $52.34M
For detailed information about INKT stock, go to TipRanks’ Stock Analysis page.